GAIN THERAPEUTICS, INC Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
GAIN THERAPEUTICS, INC (GANX) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $62.28 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $62.28K.
- 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $94.73K.
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $127.44K.
- 2025-09-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $41.21K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2026-06-30 | $62.28K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $94.73K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $127.44K 10-K · filed 2026-03-26 |
| 2025-09-30 | $41.21K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $89.59K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $125.20K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $162.99K 10-K · filed 2025-03-27 |
| 2024-09-30 | $181.59K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $190.10K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $208.51K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |